Middle East & Africa Transdermal Skin Patches Market Size & Outlook
The transdermal skin patches market in Middle East & Africa is expected to reach a projected revenue of US$ 1,110.6 million by 2030. A compound annual growth rate of 6% is expected of Middle East & Africa transdermal skin patches market from 2024 to 2030.
Revenue, 2023 (US$M)
$739.4
Forecast, 2030 (US$M)
$1,110.6
CAGR, 2024 - 2030
6%
Report Coverage
Middle East & Africa
Middle East & Africa transdermal skin patches market, 2018-2030 (US$M)
MEA transdermal skin patches market highlights
- The MEA transdermal skin patches market generated a revenue of USD 739.4 million in 2023.
- The market is expected to grow at a CAGR of 6% from 2024 to 2030.
- In terms of segment, single layer drug in adhesive was the largest revenue generating type in 2023.
- Single layer Drug in Adhesive is the most lucrative type segment registering the fastest growth during the forecast period.
MEA data book summary
| Market revenue in 2023 | USD 739.4 million |
| Market revenue in 2030 | USD 1,110.6 million |
| Growth rate | 6% (CAGR from 2023 to 2030) |
| Largest segment | Single layer drug in adhesive |
| Fastest growing segment | Single layer Drug in Adhesive |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single layer Drug in Adhesive |
| Key market players worldwide | Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Teikoku Pharma, Viatris Inc, Johnson & Johnson, Luye Pharma Group Ltd, Purdue Pharma, Henan Lingrui Pharmaceutical Co., Ltd, Samyang Biopharm USA, Hisamitsu Pharmaceutical Co Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 9.5% of the global transdermal skin patches market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- MEA is the fastest growing regional market and is projected to reach USD 1,110.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Transdermal Skin Patches Market Scope
Transdermal skin patches market segmentation & scope
Application
Pain Relief
Smoking Reduction and Cessation Aid
Cardiovascular Disorders
Neurological Disorders
Hormonal Therapy
Other Applications
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Countries
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait
Transdermal Skin Patches Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa transdermal skin patches market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
